The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $336.4 in the prior trading day, Unitedhealth Group Inc (NYSE: UNH) closed at $342.02, up 1.67%. In other words, the price has increased by $1.67 from its previous closing price. On the day, 7.97 million shares were traded. UNH stock price reached its highest trading level at $346.9399 during the session, while it also had its lowest trading level at $333.85.
Ratios:
Our goal is to gain a better understanding of UNH by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.76.
On October 14, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $406.
Robert W. Baird Downgraded its Neutral to Underperform on July 31, 2025, while the target price for the stock was maintained at $198.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’25 when Baker Charles D. sold 27 shares for $356.05 per share. The transaction valued at 9,613 led to the insider holds 0 shares of the business.
James P Schadt Trust FBO Laure bought 27 shares of UNH for $9,363 on Sep 11 ’25. On Jun 10 ’25, another insider, Conway Patrick Hugh, who serves as the Chief Executive Officer, Optum of the company, sold 589 shares for $305.00 each. As a result, the insider received 179,645 and left with 10,398 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 309814919168 and an Enterprise Value of 369362927616. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.85, and their Forward P/E ratio for the next fiscal year is 19.27. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71 while its Price-to-Book (P/B) ratio in mrq is 3.23. Its current Enterprise Value per Revenue stands at 0.849 whereas that against EBITDA is 12.631.
Stock Price History:
The Beta on a monthly basis for UNH is 0.42, which has changed by -0.34584343 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $606.36, while it has fallen to a 52-week low of $234.60. The 50-Day Moving Average of the stock is 2.98%, while the 200-Day Moving Average is calculated to be -1.65%.
Shares Statistics:
The stock has traded on average 7.63M shares per day over the past 3-months and 5636890 shares per day over the last 10 days, according to various share statistics. A total of 906.00M shares are outstanding, with a floating share count of 904.05M. Insiders hold about 0.20% of the company’s shares, while institutions hold 84.06% stake in the company. Shares short for UNH as of 1765756800 were 14831445 with a Short Ratio of 1.95, compared to 1763078400 on 12327679. Therefore, it implies a Short% of Shares Outstanding of 14831445 and a Short% of Float of 1.6400000000000001.
Dividends & Splits
In the trailing 12 months, UNH’s forward annual dividend rate was 8.62, compared to 8.73 this year. Against a Trailing Annual Dividend Yield of 0.025624257. The stock’s 5-year Average Dividend Yield is 1.53. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-12-08 with an ex-dividend date of 2025-12-08. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.
Earnings Estimates
The market rating for Unitedhealth Group Inc (UNH) is a result of the insights provided by 23.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $6.61, with high estimates of $8.05 and low estimates of $5.03.
Analysts are recommending an EPS of between $16.5 and $16.21 for the fiscal current year, implying an average EPS of $16.33. EPS for the following year is $17.77, with 27.0 analysts recommending between $19.31 and $17.05.
Revenue Estimates
19 analysts predict $113.38B in revenue for. The current quarter. It ranges from a high estimate of $115.57B to a low estimate of $109.15B. As of. The current estimate, Unitedhealth Group Inc’s year-ago sales were $100.81BFor the next quarter, 19 analysts are estimating revenue of $113.69B. There is a high estimate of $117.11B for the next quarter, whereas the lowest estimate is $107.8B.
A total of 23 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $449.67B, while the lowest revenue estimate was $443.5B, resulting in an average revenue estimate of $447.53B. In the same quarter a year ago, actual revenue was $400.28BBased on 23 analysts’ estimates, the company’s revenue will be $456.64B in the next fiscal year. The high estimate is $475.8B and the low estimate is $426.52B.
